What are the major opportunities in the Gestational Diabetes market? What are the strategies for the Gestational Diabetes market?

For detailed insights on the major opportunities and strategies in the Gestational Diabetes market, Read More

How does the Gestational Diabetes market relate to the overall economy and other similar markets?

For detailed insights on Gestational Diabetes's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Gestational Diabetes market growth? SWOT analysis of the Gestational Diabetes market.

For detailed insights on the key dynamics influencing the Gestational Diabetes market growth and SWOT analysis of the Gestational Diabetes industry, Read More

Global Gestational Diabetes Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Gestational Diabetes Global Market Report 2025

Name: Gestational Diabetes Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Types (Type A1, Type A2, Other Types), By Treatment (Monitoring, Drug Treatment, Non-pharmacological treatment), By Administration (Oral, Intravenous, Other Administrations), By End User (Hospitals, Clinics, Home Care Settings, Diagnostic Centers) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Gestational Diabetes Market Overview

• Gestational Diabetes market size has reached to $8.37 billion in 2024

• Expected to grow to $12.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%

• Growth Driver: Impact Of Rising Obesity Rates On Healthcare Demand

• Market Trend: Advancements In Diagnostic Solutions For Early Detection Of Health Conditions

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gestational Diabetes Market?

Gestational diabetes is a type of diabetes that develops during pregnancy when the body cannot produce enough insulin to regulate blood sugar levels effectively. This condition typically occurs in the second or third trimester and can affect women who have no prior history of diabetes. Gestational diabetes poses risks to both the mother and baby, including high birth weight, preterm birth, and potential development of type 2 diabetes later in life for both. It is often managed through dietary adjustments, exercise, blood sugar Monitoring, and sometimes insulin therapy to ensure a healthy pregnancy and delivery.

The main types of gestational diabetes are type A1, type A2, and other types. Gestational diabetes Type A1 refers to a form of diabetes that develops during pregnancy. It is classified under gestational diabetes mellitus (GDM), which occurs when the body cannot produce enough insulin to meet the increased needs during pregnancy. The treatment involved is monitoring, drug treatment, and non-pharmacological treatment, which are taken orally, Intravenously, and in other administrations. Hospitals, clinics, home care settings, and diagnostic centers use them.

Gestational Diabetes Market Size and growth rate 2025 to 2029: Graph

What Is The Gestational Diabetes Market Size 2025 And Growth Rate?

What Is The Gestational Diabetes Market Growth Forecast?

The gestational diabetes market size is expected to see strong growth in the next few years. It will grow to $12.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increase in rate of obesity, growing acceptance of cloud-based project arrangements and the expanding use of related devices and apps, increasing prevalence of diabetes due to unhealthy lifestyles among people, increase in public health consciousness, rising prevalence rates of diabetes. Major trends in the forecast period include digital diabetes management apps, closed-loop control systems, diabetes management technology, enzymatic technology, innovative medical technologies.

The forecast of 8.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. prenatal care by increasing costs for continuous glucose monitors and insulin pumps imported from Israel and France, potentially compromising fetal health outcomes and increasing Obstetrics and gynaecology(OB/GYN) practice costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Gestational Diabetes Market Segmented?

1) By Types: Type A1, Type A2, Other Types

2) By Treatment: Monitoring, Drug Treatment, Non-pharmacological treatment

3) By Administration: Oral, Intravenous, Other Administrations

4) By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Centers

Subsegments:

1) By Type A1: Diet-Controlled Gestational Diabetes, Exercise-Controlled Gestational Diabetes

2) By Type A2: Insulin-Controlled Gestational Diabetes, Oral Medication-Controlled Gestational Diabetes

3) By Other Types: Pre-Gestational Diabetes, Gestational Diabetes With Complications

What Is Driving The Gestational Diabetes Market? Impact Of Rising Obesity Rates On Healthcare Demand

The increasing obese population is expected to propel the growth of the gestational diabetes market going forward. The obese population is individuals whose body mass index (BMI) is 30 or higher, indicating excessive body fat that may pose significant health risks. The obese population is rising due to a combination of sedentary lifestyles, increased consumption of high-calorie, processed foods, genetic predispositions, and limited access to healthy food and exercise options. Gestational diabetes treatment is crucial for the obese population because their higher risk of insulin resistance and excessive weight gain during pregnancy can lead to complications for both mother and baby if left unmanaged. For instance, in March 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, approximately 1 in 8 people globally were living with obesity in 2022, with 2.5 billion adults aged 18 and older classified as overweight, including 890 million individuals living with obesity. Among adults, 43% were overweight, and 16% were living with obesity. Additionally, 37 million children under the age of 5 were overweight, while over 390 million children and adolescents aged 5–19 years were overweight, including 160 million living with obesity. Therefore, the increasing obese population is driving the gestational diabetes industry.

Who Are The Major Players In The Global Gestational Diabetes Market?

Major companies operating in the gestational diabetes market are Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, Dexcom Inc, Biocon Limited, LifeScan Inc, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Nipro Diagnostics, Inc., Sernova Corp., ZyVersa Therapeutics, Inc., Peptron Inc., Roche Diabetes Care, DiabetOmics Inc, Merck & Co. Inc., Medtronic plc

What Are The Key Trends Of The Global Gestational Diabetes Market? Advancements In Diagnostic Solutions For Early Detection Of Health Conditions

Major companies operating in the gestational diabetes market are focusing on developing technologically advanced products, such as diagnostic kits for gestational diabetes, to provide quick, accurate, and convenient methods for early detection. A diagnostic kit for gestational diabetes is a medical tool used to measure blood glucose levels and identify abnormal glucose tolerance in pregnant women, aiding in the early detection and management of the condition. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, launched the XpressGT RUO kit, a diagnostic kit designed to diagnose gestational diabetes, endometriosis, insulin resistance, and liver disease. It accurately measures 2-hydroxybutyrate (2-HB) levels found in venous blood, naturally produced by the liver during its normal functions. Elevated 2-HB levels are associated with increased reductive stress, linked to various endocrine and obesity-related disorders, including insulin resistance. The kit is compatible with any available clinical analyzer and delivers results in just 8 minutes, offering a fast and efficient diagnostic solution.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Gestational Diabetes Market? Strategic Partnership To Enhance Gestational Diabetes Screening In The UK

In April 2024, Digostics, a UK-based diabetes home-testing provider, partnered with AgaMatrix Europe to advance gestational diabetes screening. The partnership allows AgaMatrix to exclusively distribute Digostics' home oral glucose tolerance testing (OGTT) service, GTT@home, to the UK National Health Service (NHS), leveraging its established relationships and customer base within NHS maternity services, along with its unmatched expertise in gestational diabetes monitoring, to accelerate the product's introduction in the UK. AgaMatrix Europe is a UK-based manufacturer of blood glucose monitoring solutions.

What Is The Regional Outlook For The Global Gestational Diabetes Market?

North America was the largest region in the gestational diabetes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gestational Diabetes Market?

The gestational diabetes market consists of revenues earned by entities by providing services such as nutritional counseling, medication management, telemedicine services, lifestyle and exercise guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The gestational diabetes market also includes sales of metformin, glyburide, and insulin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Gestational Diabetes Industry?

The gestational diabetes market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gestational diabetes industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Gestational Diabetes Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$9.11 billion
Revenue Forecast In 2034	$12.78 billion
Growth Rate	CAGR of 8.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The gestational diabetes market covered in this report is segmented – 1) By Types: Type A1, Type A2, Other Types 2) By Treatment: Monitoring, Drug Treatment, Non-pharmacological treatment 3) By Administration: Oral, Intravenous, Other Administrations 4) By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Centers Subsegments: 1) By Type A1: Diet-Controlled Gestational Diabetes, Exercise-Controlled Gestational Diabetes 2) By Type A2: Insulin-Controlled Gestational Diabetes, Oral Medication-Controlled Gestational Diabetes 3) By Other Types: Pre-Gestational Diabetes, Gestational Diabetes With Complications
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, Dexcom Inc, Biocon Limited, LifeScan Inc, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Nipro Diagnostics, Inc., Sernova Corp., ZyVersa Therapeutics, Inc., Peptron Inc., Roche Diabetes Care, DiabetOmics Inc, Merck & Co. Inc., Medtronic plc
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Gestational Diabetes Market Characteristics

3. Gestational Diabetes Market Trends And Strategies

4. Gestational Diabetes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gestational Diabetes Growth Analysis And Strategic Analysis Framework

5.1. Global Gestational Diabetes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Gestational Diabetes Market Growth Rate Analysis

5.4. Global Gestational Diabetes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Gestational Diabetes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Gestational Diabetes Total Addressable Market (TAM)

6. Gestational Diabetes Market Segmentation

6.1. Global Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Type A1

Type A2

Other Types

6.2. Global Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monitoring

Drug Treatment

Non-pharmacological treatment

6.3. Global Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Other Administrations

6.4. Global Gestational Diabetes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Home Care Settings

Diagnostic Centers

6.5. Global Gestational Diabetes Market, Sub-Segmentation Of Type A1, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diet-Controlled Gestational Diabetes

Exercise-Controlled Gestational Diabetes

6.6. Global Gestational Diabetes Market, Sub-Segmentation Of Type A2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Insulin-Controlled Gestational Diabetes

Oral Medication-Controlled Gestational Diabetes

6.7. Global Gestational Diabetes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pre-Gestational Diabetes

Gestational Diabetes With Complications

7. Gestational Diabetes Market Regional And Country Analysis

7.1. Global Gestational Diabetes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Gestational Diabetes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gestational Diabetes Market

8.1. Asia-Pacific Gestational Diabetes Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gestational Diabetes Market

9.1. China Gestational Diabetes Market Overview

9.2. China Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gestational Diabetes Market

10.1. India Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gestational Diabetes Market

11.1. Japan Gestational Diabetes Market Overview

11.2. Japan Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gestational Diabetes Market

12.1. Australia Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gestational Diabetes Market

13.1. Indonesia Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gestational Diabetes Market

14.1. South Korea Gestational Diabetes Market Overview

14.2. South Korea Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gestational Diabetes Market

15.1. Western Europe Gestational Diabetes Market Overview

15.2. Western Europe Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gestational Diabetes Market

16.1. UK Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gestational Diabetes Market

17.1. Germany Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gestational Diabetes Market

18.1. France Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gestational Diabetes Market

19.1. Italy Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gestational Diabetes Market

20.1. Spain Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gestational Diabetes Market

21.1. Eastern Europe Gestational Diabetes Market Overview

21.2. Eastern Europe Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gestational Diabetes Market

22.1. Russia Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gestational Diabetes Market

23.1. North America Gestational Diabetes Market Overview

23.2. North America Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gestational Diabetes Market

24.1. USA Gestational Diabetes Market Overview

24.2. USA Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gestational Diabetes Market

25.1. Canada Gestational Diabetes Market Overview

25.2. Canada Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gestational Diabetes Market

26.1. South America Gestational Diabetes Market Overview

26.2. South America Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gestational Diabetes Market

27.1. Brazil Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gestational Diabetes Market

28.1. Middle East Gestational Diabetes Market Overview

28.2. Middle East Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gestational Diabetes Market

29.1. Africa Gestational Diabetes Market Overview

29.2. Africa Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gestational Diabetes Market Competitive Landscape And Company Profiles

30.1. Gestational Diabetes Market Competitive Landscape

30.2. Gestational Diabetes Market Company Profiles

30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

31. Gestational Diabetes Market Other Major And Innovative Companies

31.1. Becton, Dickinson and Company

31.2. Boehringer Ingelheim GmbH

31.3. Dexcom Inc

31.4. Biocon Limited

31.5. LifeScan Inc

31.6. Ascensia Diabetes Care Holdings AG

31.7. Trividia Health Inc.

31.8. Nipro Diagnostics, Inc.

31.9. Sernova Corp.

31.10. ZyVersa Therapeutics, Inc.

31.11. Peptron Inc.

31.12. Roche Diabetes Care

31.13. DiabetOmics Inc

31.14. Merck & Co. Inc.

31.15. Medtronic plc

32. Global Gestational Diabetes Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gestational Diabetes Market

34. Recent Developments In The Gestational Diabetes Market

35. Gestational Diabetes Market High Potential Countries, Segments and Strategies

35.1 Gestational Diabetes Market In 2029 - Countries Offering Most New Opportunities

35.2 Gestational Diabetes Market In 2029 - Segments Offering Most New Opportunities

35.3 Gestational Diabetes Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Gestational Diabetes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Gestational Diabetes Market, Sub-Segmentation Of Type A1, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Gestational Diabetes Market, Sub-Segmentation Of Type A2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Gestational Diabetes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Gestational Diabetes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Gestational Diabetes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Sanofi S.A. Financial Performance

Table 79: AstraZeneca plc Financial Performance

Table 80: Abbott Laboratories Financial Performance

Table 81: Eli Lilly and Company Financial Performance

Table 82: Novo Nordisk A/S Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Gestational Diabetes Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Gestational Diabetes Market, Sub-Segmentation Of Type A1, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Gestational Diabetes Market, Sub-Segmentation Of Type A2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Gestational Diabetes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Gestational Diabetes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Gestational Diabetes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Gestational Diabetes Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Gestational Diabetes Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Gestational Diabetes Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Sanofi S.A. Financial Performance

Figure 79: AstraZeneca plc Financial Performance

Figure 80: Abbott Laboratories Financial Performance

Figure 81: Eli Lilly and Company Financial Performance

Figure 82: Novo Nordisk A/S Financial Performance

From Insight to Impact: Strategic Growth Mapping in the HER2-Positive Breast Cancer Market

Hospital And Nursing Home Probiotics Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Next-Gen Implantable Cardioverter Defibrillators (ICDs) : Market Forecast, Transformation, and Long-Term Trajectories

Indwelling Catheters Growth Trajectory: Key Forecasts and Strategic Insights

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Diabetes Care Devices Market 2022 - By Type (Blood Glucose Test Strips, Lancing Devices, Continuous Glucose Monitoring Devices, Insulin Pens, Syringes, Pumps And Injectors), By Type Of Expenditure (Public, Private), By E...

Type 2 Diabetes Global Market Report 2025 – By Drug Class (Dipeptidyl Peptidase-4 (DPP-, Inhibitors, Glucagon-Like Peptide-1 (GLP-– Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And O...

Clinical Nutrition For Diabetes Care Global Market Report 2025 – By Product (Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas), By Stage (Adult, Pediatric), By Sales Channel (Online, Retail, Institutional S...

Diabetic Foods Global Market Report 2025 – By Product Type (Bakery Products, Dairy Products, Confectionery Products, Beverages, Snacks, Other Product Types), By Distribution Channel (Supermarkets and Hypermarkets, Drug S...

Instant Tea Premix Global Market Report 2025 – By Product type (Cardamom Tea Premix, Ginger Tea Premix, Masala Tea Premix, Lemon Tea Premix, Plain Tea Premix, Lemon Grass Tea Premix), By Nature ( Organic Tea Premixes, Co...

Type 1 Diabetes Global Market Report 2025 – By Product Type (Rapid Acting Insulin Analogs, Long-Acting Insulin Analogs, Premix Insulin Analogs, Others Product Types), By Device (Insulin Pump, Insulin Pen, Blood Glucose M...

Insuman Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Patient Demographics (Pediatric Patients, Adult Patients, Elderly Patients), By Distribution Channel (Hospit...

Frequently Asked Questions

What is the definition of the Gestational Diabetes market?

Gestational diabetes is a type of diabetes that develops during pregnancy when the body cannot produce enough insulin to regulate blood sugar levels effectively. This condition typically occurs in the second or third trimester and can affect women who have no prior history of diabetes. Gestational diabetes poses risks to both the mother and baby, including high birth weight, preterm birth, and potential development of type 2 diabetes later in life for both. It is often managed through dietary adjustments, exercise, blood sugar monitoring, and sometimes insulin therapy to ensure a healthy pregnancy and delivery. For further insights on this market, request a sample here

How will the Gestational Diabetes market drivers and restraints affect the market dynamics? What forces will shape the Gestational Diabetes industry going forward?

The market major growth driver - Impact Of Rising Obesity Rates On Healthcare Demand. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Gestational Diabetes market?

The gestational diabetes market size has grown strongly in recent years. It will grow from $8.37 billion in 2024 to $9.11 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increase the risk of diabetes, increased as accuracy in measuring blood glucose levels, increased number of the insurance players, increase in the population of diabetic patients, growing diabetes population. The gestational diabetes market size is expected to see strong growth in the next few years. It will grow to " $12.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increase in rate of obesity, growing acceptance of cloud-based project arrangements and the expanding use of related devices and apps, increasing prevalence of diabetes due to unhealthy lifestyles among people, increase in public health consciousness, rising prevalence rates of diabetes. Major trends in the forecast period include digital diabetes management apps, closed-loop control systems, diabetes management technology, enzymatic technology, innovative medical technologies. For further insights on this market, request a sample here

How is the Gestational Diabetes market segmented?

The gestational diabetesmarket covered in this report is segmented –
1) By Types: Type A1; Type A2; Other Types
2) By Treatment: Monitoring; Drug Treatment; Non-pharmacological treatment
3) By Administration: Oral; Intravenous; Other Administrations
4) By End User: Hospitals; Clinics; Home Care Settings; Diagnostic Centers Subsegments:
1) By Type A1: Diet-Controlled Gestational Diabetes; Exercise-Controlled Gestational Diabetes
2) By Type A2: Insulin-Controlled Gestational Diabetes; Oral Medication-Controlled Gestational Diabetes
3) By Other Types: Pre-Gestational Diabetes; Gestational Diabetes With Complications For further insights on this market, request a sample here

Which region has the largest share of the Gestational Diabetes market? What are the other regions covered in the report?

North America was the largest region in the gestational diabetes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Gestational Diabetes market?

What are the key trends in the Gestational Diabetes market?

Major trends in this market include Advancements In Diagnostic Solutions For Early Detection Of Health Conditions. For further insights on this market, request a sample here.